TOP
Nav Bar
  1. General Info
  2. Source Info
  3. Effects Info
  4. Reference
Phytochemical Details
01. General Information
Name (20S)-Protopanaxatriol
PubChem CID 11468733
Molecular Weight 476.7g/mol
Synonyms

protopanaxatriol, protopanaxatriol, (3beta,6alpha,12beta,20R)-isomer

Formula C₃₀H₅₂O₄
SMILES CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)O)C
InChI 1S/C30H52O4/c1-18(2)10-9-13-30(8,34)19-11-15-28(6)24(19)20(31)16-22-27(5)14-12-23(33)26(3,4)25(27)21(32)17-29(22,28)7/h10,19-25,31-34H,9,11-17H2,1-8H3/t19-,20+,21-,22+,23-,24-,25-,27+,28+,29+,30-/m0/s1
InChIKey SHCBCKBYTHZQGZ-CJPZEJHVSA-N
CAS Number 34080-08-5
ChEMBL ID CHEMBL255683
ChEBI ID CHEBI:75951
KEGG ID C20716
Structure 2D-img
Download
2D MOL 3D MOL
02. Source Information of Phytochemical
(1) Panax notoginseng Warm
Chineses Pinyin SanQi
Use Part Root
Habitat YunNan, GuangXi
Flavor Sweet, Mildly bitter
Meridian Tropism Liver, Stomach
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Apiales
    -->Family: Araliaceae
     -->Genus: Panax
      -->Species: Panax notoginseng
(2) Panax ginseng Warm
Chineses Pinyin RenShen
Use Part Root
Habitat JiLin, LiaoNing, HeiLongJiang
Flavor Sweet; Slightly Bitter
Meridian Tropism Spleen; Lung; Heart; Kidney
Species
>Kingdom: Viridiplantae
 -->Phylum: Streptophyta
  -->Class: Equisetopsida
   -->Order: Apiales
    -->Family: Araliaceae
     -->Genus: Panax
      -->Species: Panax ginseng
03. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Drug(s) whose resistance can be reversed by this phytochemical
Hide/Show
Combination Pair ID: 243
Pair Name (20S)-Protopanaxatriol, EGFR-TKI
Partner Name EGFR-TKI
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->Lipid accumulation
Gene Regulation Down-regulation Phosphorylation EGFR hsa1956
Down-regulation Expression SCD hsa6319
In Vitro Model HCC827 Lung adenocarcinoma Homo sapiens (Human) CVCL_2063
PC-9 Lung adenocarcinoma Homo sapiens (Human) CVCL_B260
NCI-H1975 Lung adenocarcinoma Homo sapiens (Human) CVCL_1511
HCC827-GR-high1 Lung adenocarcinoma Homo sapiens (Human) CVCL_S703
In Vivo Model Approximately 1×10⁷ H1975-luc cells were subcutaneously injected into the right hind limbs of mice.
Result Our findings uncover a link between lipid metabolic reprogramming and EGFR-TKI resistance, confirmed that combination target both EGFR and abnormal lipid metabolism maybe a promising therapy for EGFR-TKI resistance and highlighting the possibility of monitoring lipid accumulation in tumors for predicting drug resistance.
04. Reference
No. Title Href
1 Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer. J Exp Clin Cancer Res. 2019 Mar 15;38(1):129. doi: 10.1186/s13046-019-1120-4. Click
It has been 170122 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP